Inventor · disambiguated record
Kanako Shimizu
Also filed as: SHIMIZU KANAKO
7 granted patents·14 pending applications·17 citations·filing 1997–2023
78Inventor score
Top patents by PatentIndex Score
21 records- 0186US11617790B2Method for treating cancer using artificial adjuvant cell (aAVC)ASTELLAS PHARMA INC·Filed 2020·Granted Apr 4, 2023·2 cites·3 claims
- 0274US9783821B2Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid constructFUJII SHIN-ICHIRO·Filed 2012·Granted Oct 10, 2017·4 cites·7 claims
- 0366US2023381305A1METHOD FOR TREATING CANCER USING ARTIFICIAL ADJUVANT CELL (aAVC)ASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0465US2007031536A1Fermented foods and process for producing the sameYAKULT HONSHA KK·Filed 2006·Application pending·0 cites
- 0558US2024226278A1Artificial adjuvant vector cell capable of inducing immune response to coronavirus, pharmaceutical composition containing said cell, and use applications of said cell and said pharmaceutical compositionRIKEN·Filed 2022·Application pending·0 cites
- 0657US11382973B2Adjuvant composition and use thereofRIKEN·Filed 2017·Granted Jul 12, 2022·0 cites·9 claims
- 0756US2023303631A1METHOD FOR INDUCING IMMUNITY TO SARS-CoV-2RIKEN·Filed 2021·Application pending·0 cites
- 0854US10416160B2Memory invariant NKT cell markerRIKEN·Filed 2015·Granted Sep 17, 2019·0 cites·10 claims
- 0953US2016195530A1Method for analysis of nkt cell functionRIKEN·Filed 2016·Application pending·0 cites
- 1051US2022251574A1Cell capable of activating immune system, and pharmaceutical composition containing said cellRIKEN·Filed 2020·Application pending·0 cites
- 1151US2022296705A1Combined use of artificial adjuvant vector cells and an immunostimulantRIKEN·Filed 2020·Application pending·0 cites
- 1250US2009233323A1Method for analysis of nkt cell functionRIKEN·Filed 2006·Application pending·0 cites
- 1348US11834674B2Modified immunocyte, method for producing modified immunocyte and utilization thereofRIKEN·Filed 2015·Granted Dec 5, 2023·0 cites·12 claims
- 1448US2013189302A1Immunotherapeutic method using artificial adjuvant vector cells that co-express cd1d and target antigenRIKEN·Filed 2013·Application pending·0 cites
- 1548US2010330057A1Method of evaluating human dentritic cells and human cell immunotherapeutic agentRIKEN·Filed 2008·Application pending·0 cites
- 1646US2004121042A1Fermented foods and process for producing the sameYAKULT HONSHA KK·Filed 2001·Application pending·0 cites
- 1746US2011280895A1IMMUNOTHERAPEUTIC METHOD USING ALLO-CELLS WHICH CO-EXPRESS CD1d AND TARGET ANTIGENFUJII SHIN-ICHIRO·Filed 2009·Application pending·0 cites
- 1845US2011020932A1In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitutionRIKEN·Filed 2007·Application pending·0 cites
- 1944US5980856ASynthetic chalcoalumite-type compounds and processes for producing the sameKYOWA CHEM IND CO LTD·Filed 1997·Granted Nov 9, 1999·7 cites·6 claims
- 2044US2010233215A1IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGANDRIKEN·Filed 2007·Application pending·0 cites
- 2134US5861133ASynthetic chalcoalumite compounds and process for producing thereofKYOWA CHEM IND CO LTD·Filed 1997·Granted Jan 19, 1999·4 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Kanako Shimizu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →